After academic medical centers began instituted policies that restricted sales reps from having access to physicians, prescribing antidepressants and antipsychotics for unapproved uses declined. Aaron Kesselheim, assistant professor of medicine at Brigham and Women's Hospital, is a coauthor of the study.